Ortho Clinical Diagnostics in the News

Ortho Clinical Diagnostics Celebrates 1,000 Installations of the ORTHO VISION® Platform Worldwide

January 24, 2017
Media Alert

RARITAN, N.J. – January 24, 2017 – The award-winning ORTHO VISION® platform, a portfolio of fully automated blood analyzers for use in transfusion medicine laboratories, has surpassed 1,000 installations worldwide.  The portfolio is comprised of the ORTHO VISION Analyzer, for use in small- to medium-volume transfusion medicine laboratories and the ORTHO VISION Max analyzer, for high-volume transfusion medicine laboratories.  

The accomplishment is recognition of the ORTHO VISION platform’s value to customers, and represents faster growth than Ortho’s previous products in this space. This accomplishment also builds on Ortho’s proven track record of innovation in the transfusion medicine industry, delivering the only integrated instrument suite that is part of a larger portfolio of products and services.

Tailored to the needs of any facility, the ORTHO VISION platform helps improve workflow and supports the standardization of systems and processes, helping blood banks keep pace with growing industry pressure to increase productivity while remaining operationally efficient.

“ORTHO VISION reaching its 1000th installation is a testament to our ongoing commitment to innovating and meeting the needs of the hospitals and blood banks we serve,” said Heidi Casaletto, head of transfusion medicine at Ortho Clinical Diagnostics. “Our customers have embraced our platform and contributed to this success. We look forward to continuing these relationships and building upon our innovative portfolio.”